SEP
MRNA icon

Signature Equity Partners’s Moderna MRNA Stock Holding History

Signature Equity Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$910 Sell
13
-8
-38% -$414 ﹤0.01% 1334
2026
Q1 		$1.07K Buy
21
+13
+163% +$607 ﹤0.01% 1236
2025
Q4 		$236 Buy
+8
New +$217 ﹤0.01% 1626

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Signature Equity Partners's MRNA Position: Q2 2026 in Review

Signature Equity Partners reduced its Moderna (MRNA) stake by 38% in Q2 2026, selling an estimated $414 and leaving 13 shares worth $910. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

Signature Equity Partners first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.07K in Q1 2026. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Signature Equity Partners held 13 shares of Moderna worth $910 as of Q2 2026.
  • Signature Equity Partners sold 8 Moderna shares in Q2 2026, an estimated $414.
  • Moderna made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1334 holding.
  • Signature Equity Partners first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Moderna position peaked at $1.07K in Q1 2026.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.